Zydus Cadila announced that it has completed the dosing of 1,000 volunteers in the phase 2 trials of its COVID-19 vaccine candidate ZyCoV-D. The company said that the immunogenicity evaluation of the trial is going on.
Meanwhile, Donald Trump on November 2 closed his final campaign before the US elections with a remark warning that a Joe Biden presidency may mean another national lockdown for the country.
Tune in to the Coronavirus Essential podcast with Sakshi Batra for more.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
